VMD Medicines Update - January 2022 | British Equine Veterinary Association
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us
BEVA Logo
  1. Resources
  2. Education
  3. Career support
  4. Get involved
  5. About us

VMD Medicines Update - January 2022

News Medicines
04 Mar 2022 BEVA

This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.

New marketing authorisations

Table 1 shows the new marketing authorisations for January 2022.

TABLE 1: New marketing authorisations in January 2022

New Marketing Authorisations

Product name and target species

Active substance

Authorisation Holder, territory, and distribution category

Therapeutic group

 

Food animals

Geepenil vet 300 mg/ml powder for solution for injection

 

Benzylpenicillin Sodium

Orion Corporation

Authorised in UK

POM-V

Antimicrobial

See the VMD’s Product Information Database for more information on each of these products. This includes separate links for the authorisation territories of Great Britain and Northern Ireland.

Please note, there may be a delay between the issuing of a marketing authorisation and the product being placed on the market.

For more information, contact the VMD at postmaster@vmd.gov.uk